This trial is combination of PDL (Medimmune) with the GSK braf/mek combo for Braf positive OR combined with just the MEK for BRAF neg folks.
If you are interested please email me and I will send you the nearest location, it is too long for me to list all here. My email is: cpoole@melanomainternational.org
I truly think this will be a fascinating trial with very few exclusions except no prior BRAF or MEK drug. Prior PD1 is ok as well as IPI. The trial is: NCT02027961